{"id": 1509565356268044296, "geo": null, "lang": "en", "text": "Disappointed to see @US_FDA\u2019s vote against Amylyx's ALS drug.\n \nWe need my Promising Pathway Act to provide the reg\u2026 https://t.co/im5ruLgEs0", "user": {"id": 1080870981877534720, "url": "http://braun.senate.gov", "lang": null, "name": "Senator Mike Braun", "id_str": "1080870981877534720", "location": "Jasper, IN", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Thu Jan 03 16:58:18 +0000 2019", "utc_offset": null, "description": "Main Street businessman & Hoosier U.S. Senator for Indiana", "geo_enabled": true, "screen_name": "SenatorBraun", "listed_count": 940, "friends_count": 320, "is_translator": false, "notifications": null, "statuses_count": 3543, "default_profile": false, "followers_count": 36431, "translator_type": "none", "favourites_count": 42, "profile_image_url": "http://pbs.twimg.com/profile_images/1080872040184401924/tXytvVUd_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/1080870981877534720/1616623815", "profile_link_color": "1B95E0", "profile_text_color": "000000", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1080872040184401924/tXytvVUd_normal.jpg", "profile_background_color": "000000", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1509565356268044296", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/im5ruLgEs0", "indices": [117, 140], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1509565356268044296"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 208120290, "name": "U.S. FDA", "id_str": "208120290", "indices": [20, 27], "screen_name": "US_FDA"}]}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Thu Mar 31 16:16:41 +0000 2022", "coordinates": null, "quote_count": 0, "reply_count": 0, "contributors": null, "filter_level": "low", "timestamp_ms": "1648743401959", "retweet_count": 0, "extended_tweet": {"entities": {"urls": [], "symbols": [], "hashtags": [], "user_mentions": [{"id": 208120290, "name": "U.S. FDA", "id_str": "208120290", "indices": [20, 27], "screen_name": "US_FDA"}]}, "full_text": "Disappointed to see @US_FDA\u2019s vote against Amylyx's ALS drug.\n \nWe need my Promising Pathway Act to provide the regulatory framework necessary for rare disease drug development and expediting beneficial outcomes for patients.\n\nThe ALS community does not have time to lose.", "display_text_range": [0, 272]}, "favorite_count": 0, "is_quote_status": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}